These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 20477206)

  • 1. Potential of imatinib mesylate as a novel treatment for pulmonary fibrosis.
    Chhina M; Shlobin OA; Grant G; Nathan SD
    Expert Rev Respir Med; 2008 Aug; 2(4):419-31. PubMed ID: 20477206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic pulmonary fibrosis: current trends in management.
    Raghu G; Chang J
    Clin Chest Med; 2004 Dec; 25(4):621-36, v. PubMed ID: 15564012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens.
    Fiorucci E; Lucantoni G; Paone G; Zotti M; Li BE; Serpilli M; Regimenti P; Cammarella I; Puglisi G; Schmid G
    Eur Rev Med Pharmacol Sci; 2008; 12(2):105-11. PubMed ID: 18575160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of idiopathic pulmonary fibrosis: is there anything new?
    Abdelaziz MM; Samman YS; Wali SO; Hamad MM
    Respirology; 2005 Jun; 10(3):284-9. PubMed ID: 15955138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Idiopathic pulmonary fibrosis; description of a Dutch cohort].
    Barlo NP; van Moorsel CH; van den Bosch JM; van de Graaf EA; Kwakkel-van Erp JM; Grutters JC
    Ned Tijdschr Geneeskd; 2009; 153():B425. PubMed ID: 19785823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in the therapy of pulmonary fibrosis.
    Scriabine A; Rabin DU
    Adv Pharmacol; 2009; 57():419-64. PubMed ID: 20230768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bosentan for idiopathic pulmonary fibrosis.
    Swigris JJ; Brown KK
    Expert Rev Respir Med; 2008 Jun; 2(3):315-21. PubMed ID: 20477195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis.
    Azuma A
    Expert Rev Respir Med; 2010 Jun; 4(3):301-10. PubMed ID: 20524912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging drugs for idiopathic pulmonary fibrosis.
    Thannickal VJ; Flaherty KR; Hyzy RC; Lynch JP
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):707-27. PubMed ID: 16262559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Idiopathic pulmonary fibrosis].
    Doubková M; Skhicková J
    Vnitr Lek; 2005 Dec; 51(12):1375-84. PubMed ID: 16430105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future therapeutic approaches in idiopathic pulmonary fibrosis.
    Bouros D; Antoniou KM
    Eur Respir J; 2005 Oct; 26(4):693-702. PubMed ID: 16204603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of idiopathic pulmonary fibrosis].
    Valeyre D; Dion G
    Bull Acad Natl Med; 2010 Feb; 194(2):367-81; discussion 381-2. PubMed ID: 21166125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic pulmonary fibrosis.
    Balamugesh T; Behera D
    J Assoc Physicians India; 2007 May; 55():363-70. PubMed ID: 17844698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
    Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
    Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of idiopathic pulmonary fibrosis: Implications for respiratory care.
    Hospenthal MA
    Respir Care; 2006 Apr; 51(4):382-91. PubMed ID: 16563193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
    Klingsberg RC; Mutsaers SE; Lasky JA
    Respirology; 2010 Jan; 15(1):19-31. PubMed ID: 20199632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pulmonary fibrosis for twenty weeks with imatinib mesylate in a patient with mixed connective tissue disease.
    Distler JH; Manger B; Spriewald BM; Schett G; Distler O
    Arthritis Rheum; 2008 Aug; 58(8):2538-42. PubMed ID: 18668536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib mesylate: clinical results in Philadelphia chromosome-positive leukemias.
    Kantarjian HM; Talpaz M
    Semin Oncol; 2001 Oct; 28(5 Suppl 17):9-18. PubMed ID: 11740802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New treatment options for idiopathic pulmonary fibrosis?].
    Gutjahr K; Gillissen A
    Pneumologie; 2009 Sep; 63(9):512-8. PubMed ID: 19708007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung transplantation for idiopathic pulmonary fibrosis.
    Mason DP; Brizzio ME; Alster JM; McNeill AM; Murthy SC; Budev MM; Mehta AC; Minai OA; Pettersson GB; Blackstone EH
    Ann Thorac Surg; 2007 Oct; 84(4):1121-8. PubMed ID: 17888957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.